Key result
Epstein-Barr virus linked to fatal dilated cardiomyopathy with 12% LVEF in an immunocompetent male.
Why the study?
Epstein-Barr virus rarely causes myocarditis, which can progress to dilated cardiomyopathy and acute congestive heart failure with multivalvular regurgitation, but early diagnosis and treatment importance is underemphasized.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
This case highlights the importance of early diagnosis and treatment of Epstein-Barr virus myocarditis to prevent progression to dilated cardiomyopathy, heart failure, and mortality.
). Epstein-Barr virus (EBV) rarely causes myocarditis, which is a life-threatening complication. Autoantibodies against cardiac myocytes activate the complement system and cause diffuse myocyte necrosis. Myocarditis has a variable presentation from asymptomatic to cardiogenic shock. Over time, untreated myocarditis can progress and result in dilated ventricles. Continued dilation of ventricles leads to systolic dysfunction, conduction abnormalities, ventricular arrhythmia, heart failure, valvular abnormalities, and thromboembolism. So, we are emphasizing the importance of early diagnosis and treatment of EBV to prevent mortality. This case study represents a rare case of mortality secondary to EBV infection with resultant DCM and congestive heart failure (CHF).
No takes yet. Share an insight, caveat, or question.
Aknouk et al. (2022) conducted a case report in Epstein-Barr Virus Myocarditis (n=1). Epstein-Barr virus infection was evaluated on Clinical outcome (mortality). Epstein-Barr virus infection in a 20-year-old immunocompetent male led to severe dilated cardiomyopathy with an ejection fraction of 12%, cardiogenic shock, and ultimately death.
Synapse has enriched 10 related papers. Consider them for comparative context: